Home
Live Updates
Inhibikase Therapeutics Reports First Quarter Financial Results and Highlights Recent Period Activity : comparemela.com
Inhibikase Therapeutics Reports First Quarter Financial Results and Highlights Recent Period Activity
Company to host conference call on Thursday, May 16, 2024 at 8:00 a.m. ETBOSTON and ATLANTA, May 15, 2024 -- Inhibikase Therapeutics, Inc. , a clinical-stage pharmaceutical company developing...
Related Keywords
Boston ,
Massachusetts ,
United States ,
Atlanta ,
Georgia ,
Alex Lobo ,
Miltonh Werner ,
Facebook ,
Nasdaq ,
Office Of Cardiology ,
Division Of Cardiology ,
Sternir Inc ,
Linkedin ,
Company Contact ,
Steam Review ,
Exchange Commission ,
Inhibikase Or Company ,
Division Of Hematologic Malignancies ,
Youtube ,
Inhibikase Therapeutics Inc ,
Abelson Tyrosine Kinases ,
Chief Executive Officer ,
Upcoming Milestones ,
Meeting Minutes ,
Hematologic Malignancies ,
Review Team ,
Pulmonary Arterial Hypertension ,
Final Meeting Minutes ,
Abelson Tyrosine Kinase ,
Abelson Tyrosine ,
Multiple System Atrophy ,
Private Securities Litigation Reform Act ,
Consolidated Statements ,
Comprehensive Loss ,
Months Ended March ,
comparemela.com © 2020. All Rights Reserved.